ERISYON INC
Fluorosequencing platform for single-molecule protein sequencing and quantification
- Sector
- Medtech
- Headquarters
- Brooklyn, NY
- Total capital
- $690K
- Federal grants
- $690K
- 3 awards · 2020–2022
- Rank in peer group#20 of 95
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 17 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Structural profiling of native proteins using fluorosequencing, a single molecule protein sequencing technology$217K
- Federal grantHealth and Human S · Phase I · Single molecule protein sequencing of alpha-synuclein species for Parkinson's disease diagnostics$248K
- Federal grantNSF · Phase I · STTR Phase I: Single molecule sequencing of phosphorylated proteins for next-generation protein analyses and diagnostics$225K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 95 peers
Line = medianMedtech · Instrument
- Federal grants#20 · top 21%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 17- PendingFluorophore-polymer Conjugates And Uses ThereofUSPTOApplication 19117778
- PendingMethods And Systems For Automated Sample ProcessingUSPTOApplication 18710558
- PendingStructural Profiling Of Native Proteins Using Fluorosequencing, A Single Molecule Protein Sequencing TechnologyUSPTOApplication 18697605
Show all 17 patent records
- Fluorophore-polymer Conjugates And Uses ThereofApr 30, 2026 · Application 19117778Pending
- Methods And Systems For Automated Sample ProcessingJan 30, 2025 · Application 18710558Pending
- Structural Profiling Of Native Proteins Using Fluorosequencing, A Single Molecule Protein Sequencing TechnologyDec 26, 2024 · Application 18697605Pending
- Compositions, Methods, And Utility Of Conjugated Biomolecule BarcodesJun 20, 2024 · Application 18518854Pending
- Fluorophore-polymer Conjugates And Uses ThereofApplication 63582766Pending
- Methods And Systems For Automated Sample ProcessingApplication PCTUS2022079979Pending
- Use Of Tethers To Mitigate Dye-dye InteractionsApplication 63412780Pending
- Methods Of Mapping Post-translational Modifications On ProteinsApplication 63397687Pending
- Compositions, Methods, And Utility Of Conjugated Biomolecule BarcodesApplication PCTUS2022031079Pending
- Methods And Systems For Automated Sample ProcessingApplication 63280291Pending
- Composition, Methods And Utility Of Conjugated Peptide BarcodesApplication 63193436Pending
- Single Molecule N-terminal Sequencing Using Electrical SignalsApplication PCTUS2021027155Pending
- Single Molecule N-terminal Sequencing Using Electrical SignalsApplication 63009240Pending
- Methods For Labeling N-terminal Glycine For ProteomicsApplication 19102878Pending
- Methods For Profiling Immunoglobulin RepertoiresApplication PCTUS2025013042Pending
- METHOD FOR PROFILING PATIENT-SPECIFIC IgG REPERTOIREApplication 63625266Pending
- Fluorophore-polymer Conjugates And Uses ThereofApplication PCTUS2023075739Pending
Related companies, and why
- VIDA DIAGNOSTICS, INC.Similar federal contract value in Medtech · null in contracts
- Yesse Technologies, Inc.Similar federal contract value in Medtech · null in contracts
- Pace Surgical, Inc.Similar federal contract value in Medtech · null in contracts
- Ventaris Surgical, Inc.Similar federal contract value in Medtech · null in contracts
- Quelliv, Inc.Similar federal contract value in Medtech · null in contracts
- Applied Separations, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .